Strep in Pigs: Symptoms and What They Mean

Streptococcus suis infection in pigs produces a range of symptoms that can look dramatically different from one animal to the next, from wobbly walking and head tilting to swollen joints, labored breathing, and sudden death with no warning signs at all. The bacterium is one of the most economically damaging pathogens in the global swine industry, and it also poses a real risk to people who work closely with pigs or handle raw pork. Understanding what each symptom actually signals helps producers respond faster and, in some cases, prevent the worst outcomes.

What Streptococcus Suis Actually Is

Streptococcus suis is a group of bacterial strains that colonize pigs, particularly the tonsils and upper respiratory tract. It ranks among the most significant bacterial threats to commercial swine production worldwide and is increasingly recognized as a zoonotic pathogen capable of causing serious illness in humans, including meningitis, blood poisoning, and arthritis.¹ There are dozens of known serotypes, with serotype 2 historically responsible for the majority of clinical disease in both pigs and humans, though several others cause trouble depending on the region.

How Pigs Carry and Spread It

One reason S. suis is so difficult to stamp out is that many pigs carry it without showing any symptoms. The bacterium lodges in the tonsils and can persist there for extremely long periods. In one study, researchers detected S. suis type 2 in the tonsils of individual pigs for up to 521 days, even when those pigs had circulating antibodies against it and were receiving penicillin in their feed.² That same study confirmed that weaned carrier pigs readily passed the infection to previously uninfected pigs when mixed together. In practical terms, this means a herd can harbor S. suis indefinitely, with outbreaks triggered by stress, mixing, or a dip in immunity rather than by new introductions from outside.

Transmission happens mainly through nose-to-nose contact, shared airspace, and contaminated secretions. Sows often pass the bacterium to piglets during or shortly after birth. Because colonization happens so early in life, management strategies like early weaning have limited power to break the cycle.³

Nervous System Symptoms

The most recognizable presentation of S. suis in pigs involves the central nervous system. Meningitis, an inflammation of the membranes surrounding the brain and spinal cord, is the hallmark. Affected pigs may paddle their legs while lying on their side, tilt their heads, walk in circles, show incoordination, or become completely unable to stand. Some develop a stiff, arched posture. Trembling and nystagmus (rapid, involuntary eye movements) are common in severe cases. These neurological signs tend to appear suddenly, often in pigs that seemed perfectly healthy hours earlier.

When researchers examined pigs that died with nervous signs, they consistently found purulent meningitis on post-mortem examination.⁴ The bacterium has a sophisticated toolkit for crossing the blood-brain barrier, which is why meningitis is such a frequent outcome once the infection reaches the bloodstream.⁵

Sudden Death with No Warning

Perhaps the most unsettling aspect of S. suis is that some pigs die acutely with no outward signs of illness beforehand. A pig that appeared healthy at evening checks is found dead in the morning. In a clinical review from Ontario, researchers noted that death with no premonitory signs was one of the recognized presentation patterns alongside nervous and respiratory disease.⁴ This pattern usually reflects acute septicemia, where the bacterium multiplies rapidly in the blood and overwhelms the pig before the immune system or the producer can respond.

Septicemia can also produce less dramatic but still alarming signs: high fever, reddened or blotchy skin, depression, reluctance to eat, and rapid deterioration over a few hours. Because these signs overlap with many other bacterial infections, a definitive diagnosis usually requires laboratory work.

Joint Swelling and Lameness

Arthritis is another common expression of S. suis infection. You may notice one or more joints visibly swollen, typically the hock, knee, or carpus. Affected pigs are reluctant to bear weight on the affected limb, may shift from foot to foot, or refuse to stand altogether. In a herd outbreak, it is not unusual to see a mix of neurological and arthritic cases, sometimes in the same pig. Joint infections can persist as chronic problems if not treated promptly, leading to lasting lameness and poor growth.

Heart Involvement

S. suis can target the heart in ways that often go unrecognized until post-mortem examination. Endocarditis, where bacterial colonies build up on the heart valves, is a well-documented finding. In one detailed pathological study, 21 pigs with vegetative valvular endocarditis were identified, most of them over ten weeks old. The majority had died suddenly, and the left atrioventricular valve was affected in 18 of the 21 hearts. Much of the valve surface was replaced by a layer of granulation tissue covered in fibrin, inflammatory cells, and masses of bacteria.⁶

The same study also documented pericarditis (inflammation of the sac around the heart) and a hemorrhagic, necrotizing form of myocarditis that closely resembled mulberry heart disease, a condition more commonly linked to vitamin E or selenium deficiency. That resemblance is worth knowing because it can lead to misdiagnosis if laboratory confirmation is skipped. A separate clinical review confirmed that myocardial necrosis, focal myocarditis, and valvular endocarditis were all found alongside the more expected meningitis and polyserositis in S. suis cases.⁴ Another case report documented S. suis serotype 9 causing both endocarditis and severe meningitis in the same growing pig.⁷

From a practical standpoint, sudden death in grower-finisher pigs with no prior signs of illness should always prompt a post-mortem that includes careful inspection of the heart. Endocarditis easily goes unseen if the heart is not opened and examined.

Respiratory Signs and Co-Infections

Respiratory disease caused by S. suis on its own tends to be less dramatic than the neurological or septicemic forms. Coughing, labored breathing, and nasal discharge can occur, but the real danger with the respiratory tract lies in co-infections. S. suis has long been considered a secondary player in the porcine respiratory disease complex, where it piles on top of primary viral infections to worsen outcomes considerably.⁸

The pairing with porcine reproductive and respiratory syndrome virus (PRRSV) is particularly damaging. Research has shown that PRRSV infection accelerates S. suis invasion and multiplication in blood and tissues, resulting in more severe pneumonia, myocarditis, and peritonitis, along with higher mortality.⁹ Experimental co-infection with a highly pathogenic PRRSV strain and S. suis serotype 7 produced higher bacterial isolation rates and more severe lung lesions than either infection alone.¹⁰ If you are seeing respiratory problems alongside neurological or joint symptoms, the chances are high that a viral infection is running in the background and giving S. suis an opening.

Why Nursery Pigs Are the Most Vulnerable

S. suis disease is heavily concentrated in the nursery phase, the weeks immediately after weaning. The timing is not a coincidence. Piglets receive protective antibodies from their mother’s colostrum, but those maternal antibodies fade rapidly during the suckling period. Research tracking antibody levels against S. suis serotypes 2 and 9 found that maternal antibody levels hit their lowest point around days 18 to 19 of life. After weaning, the piglets’ own immune response begins to develop and antibody levels gradually climb, but there is a gap of several weeks where protection is minimal.¹¹

Weaning itself compounds the problem. Piglets are separated from the sow, mixed with unfamiliar pigs, moved to a new environment, and switched to solid feed, all within a short window. Each of those stressors taxes the immune system. When a nursery outbreak takes hold, it can be severe. Data from one outbreak study recorded average post-weaning mortality of about 14% and found that if a pig’s littermate had died, the risk for that pig jumped dramatically.¹² Interestingly, the same study found that sows whose first litter experienced mortality during the study produced piglets with a lower risk of dying in their second litter, suggesting that repeated exposure in the sow boosted the protective quality of her colostrum.

Diseases That Look Similar

Several other bacteria cause nearly identical clinical pictures in young pigs, which is why lab diagnosis matters. Haemophilus parasuis (Glässer’s disease) produces polyserositis, arthritis, and meningitis that can be indistinguishable from S. suis on physical exam alone. Actinobacillus suis causes septicemia and sudden death that mimics the acute S. suis form. All three have been grouped informally as the “suis-ide diseases” because of their overlapping severity and the fact that they colonize piglets early in life.³ Erysipelas, caused by Erysipelothrix rhusiopathiae, can also produce joint swelling and endocarditis that looks like S. suis on post-mortem. Without culture or molecular testing, guessing the pathogen from symptoms alone is unreliable.

Molecular tools have made identification faster and more precise. A multiplex PCR assay developed for S. suis can detect the bacterium directly from tonsil swabs without needing a culture step first, with a detection threshold as low as 28 colony-forming units per milliliter.¹³ That kind of sensitivity is useful for identifying subclinical carriers in a herd, not just confirming infection in sick pigs.

Treatment and the Antibiotic Resistance Problem

Early antibiotic treatment can save pigs if it is started before the infection progresses too far. Penicillin and ampicillin have historically been the first-line choices because S. suis tends to remain susceptible to beta-lactams more consistently than to other classes. However, antibiotic resistance is a growing concern. In countries where antibiotics are used extensively in swine production, resistance has spread across multiple drug classes.¹⁴ Tetracycline resistance, in particular, is now widespread in many regions.

The practical challenge is that by the time a pig shows clear symptoms of meningitis or septicemia, the infection may already be advanced enough that antibiotics have limited effect. Pigs with severe neurological signs often fail to recover fully even with aggressive treatment. Injectable antibiotics reach therapeutic levels faster than in-feed medication and are preferred for individual sick animals. In-feed or water medication is used more for metaphylaxis, treating the group around the sick pig to catch infections before they become clinical.

The Vaccination Gap

There is currently no widely available commercial vaccine that reliably protects against S. suis across serotypes and regions. The diversity of serotypes, virulence factors, and strain-to-strain variation has made developing a universal vaccine extremely difficult. What many producers use instead are autogenous vaccines, custom-made from bacterial strains isolated from a specific herd. These are typically administered to gilts and sows before farrowing with the goal of boosting the antibodies passed through colostrum to piglets.¹⁵

Results are mixed. Some farms report clear reductions in nursery mortality after starting a sow vaccination program. Others see little change, particularly if the circulating strains on the farm do not match the vaccine strains well or if the immunity gap after weaning is too long for maternal antibodies to bridge. There is no universal standardization in how autogenous vaccines are produced, so quality and effectiveness vary between manufacturing laboratories.

The Economic Toll

S. suis disease is endemic in major pork-producing countries and hits the nursery phase hardest. An economic assessment of farms in Germany, the Netherlands, and Spain found that in affected nursery units, roughly 3 to 4% of pigs developed S. suis-associated disease, with mortality in those units ranging from about 0.5 to 0.9%. When costs were tallied across all production phases, the average cost per pig came to about €1.30 in Germany, €0.96 in the Netherlands, and €0.60 in Spain.¹⁶ Those per-pig figures may sound small, but multiplied across the millions of pigs produced annually in each country, the aggregate cost is substantial. The figures also do not capture indirect losses like reduced growth rates in subclinically affected animals or the cost of extra labor and veterinary intervention during outbreaks.

When Pigs Pass It to People

S. suis is not just a veterinary concern. Human infections, while still relatively uncommon in Western countries, have been increasing globally, particularly in Southeast Asia. The most common clinical picture in humans is meningitis, which accounted for about 68% of reported cases in a large systematic review. Sepsis, arthritis, endocarditis, and eye infections also occur. The pooled case-fatality rate across published studies was roughly 13%, and among survivors, hearing loss affected about 39% and vestibular dysfunction about 23%.¹⁷

The primary risk factors for human infection are occupational exposure to pigs and consumption of raw or undercooked pork products. In the same review, about 38% of patients had pig-related occupations, and about 37% had a history of eating high-risk food. A case report from Korea illustrated the pattern: a 67-year-old pig carcass handler developed S. suis meningitis with dizziness and bilateral hearing loss. Even after antibiotic treatment, the hearing loss and vestibular problems persisted.¹⁸ For anyone working in pig barns, slaughterhouses, or meat processing, the presence of S. suis in a herd is a personal health consideration, not just a production issue. Covering cuts and wounds, wearing gloves during handling, and thoroughly cooking pork are the basic protective measures.

Emerging Research on Tonsil Probiotics

Because S. suis lives in the tonsils and cannot easily be eliminated with antibiotics or current vaccines, researchers have started looking at whether other bacteria naturally present in the pig tonsil could outcompete or suppress it. A recent study used deep sampling of the pig tonsil microbiome and identified two previously undescribed bacterial species, a Brevibacterium and a Corynebacterium, that produced antimicrobial compounds active against S. suis in laboratory tests. The Corynebacterium species produced a stable variant of a compound called flavucin that inhibited the growth of both S. suis and Staphylococcus aureus.¹⁹ The work is still at the laboratory stage, and whether these organisms could be used as practical probiotics in live pigs remains to be tested. But the approach represents a fundamentally different angle on a pathogen that has stubbornly resisted conventional control measures for decades. If it pans out, colonizing piglet tonsils with beneficial bacteria early in life could reduce the carrier state that drives herd-level disease.